In the new WHO–European Organisation for Research and Treatment of Cancer (WHO-EORTC) classification for cutaneous lymphomas three major groups of primary cutaneous B-cell lymphoma (CBCL) are ...

R-ESHAP as salvage therapy in patients with relapsed or refractory diffuse large B-cell lymphoma: A prospective phase II study. This is an ASCO Meeting Abstract from the 2011 ASCO Annual Meeting I.

As a Houston high school senior, Dr. Ami Steinberg’s unexpected Hodgkin lymphoma diagnosis, which was discovered after a ...

Large B-cell lymphomas, with an estimated 150,000 new cases annually worldwide, represent almost 30% of all cases of non-Hodgkin’s lymphoma. Patients typically present with progressive lymphadenopathy ...

It develops from the abnormal multiplication of T cells, or T-lymphocytes, a type of white blood cell essential for immune system function. The specific treatment course and prognosis for T-cell ...

Oncologists share the number-one sign of lymphoma that you shouldn't ignore, plus other symptoms that may signal this rare ...

AYA lymphoma patients often experience delayed diagnosis due to transitional life stages and lack of primary care or insurance. Lymphoma types and presentations in AYAs differ from those in children ...

Please provide your email address to receive an email when new articles are posted on . Circulating tumor DNA can be readily detected in patients with central nervous system lymphoma and may be a ...

Hodgkin lymphoma (formerly known as Hodgkin disease), which involves an abnormal type of lymphocyte called Reed-Sternberg cells Non-Hodgkin lymphoma, which does not contain Reed-Sternberg cells Both ...

A medical diagnosis that includes the word "indolent" may not be a bad thing. It can mean a "lazy" condition that is slow-moving. That is often the case with indolent lymphomas. Sometimes watchful ...